arjunolic acid has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajeesh Krishna, TP; Al-Dhabi, NA; Antony Caesar, S; Balakrishna, K; Buvanesvaragurunathan, K; Esakkimuthu, S; Ignacimuthu, S; Pandikumar, P; Stalin, A; Sylvester Darvin, S; Toppo, E | 1 |
| Chandra, M; Day, A; Maxey, B; Miriyala, S; Panchatcharam, M; St Clair, DK | 1 |
2 other study(ies) available for arjunolic acid and Disease Models, Animal
| Article | Year |
|---|---|
Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models.
Topics: Animals; Cell Survival; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Hep G2 Cells; Humans; Male; Non-alcoholic Fatty Liver Disease; PPAR alpha; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Terminalia; Triglycerides; Triterpenes; Up-Regulation | 2018 |
Arjunolic acid ameliorates reactive oxygen species via inhibition of p47(phox)-serine phosphorylation and mitochondrial dysfunction.
Topics: Animals; Antioxidants; Disease Models, Animal; Gene Expression Regulation; Glycolysis; Humans; Lysosomes; Male; Mice; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Infarction; NADPH Oxidases; Neutrophils; Oxidative Phosphorylation; Oxidative Stress; Phosphorylation; Primary Cell Culture; Signal Transduction; Superoxides; Tetradecanoylphorbol Acetate; Triterpenes | 2015 |